When Should You Buy UPL Limited (NSE:UPL)?

While UPL Limited (NSE:UPL) might not have the largest market cap around , it led the NSEI gainers with a relatively large price hike in the past couple of weeks. The recent jump in the share price has meant that the company is trading at close to its 52-week high. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Today we will analyse the most recent data on UPL’s outlook and valuation to see if the opportunity still exists.

View our latest analysis for UPL

Advertisement

What Is UPL Worth?

The stock seems fairly valued at the moment according to our valuation model. It’s trading around 10% below our intrinsic value, which means if you buy UPL today, you’d be paying a fair price for it. And if you believe that the stock is really worth ₹705.46, then there’s not much of an upside to gain from mispricing. Although, there may be an opportunity to buy in the future. This is because UPL’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

What does the future of UPL look like?

earnings-and-revenue-growth
NSEI:UPL Earnings and Revenue Growth March 1st 2025

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. UPL's revenue growth are expected to be in the teens in the upcoming years, indicating a solid future ahead. Unless expenses grow at the same level, or higher, this top-line growth should lead to robust cash flows, feeding into a higher share value.

What This Means For You

Are you a shareholder? UPL’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

Are you a potential investor? If you’ve been keeping tabs on UPL, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

If you want to dive deeper into UPL, you'd also look into what risks it is currently facing. For example - UPL has 1 warning sign we think you should be aware of.

If you are no longer interested in UPL, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:UPL

UPL

Manufactures and sells pesticides, insecticides, and micronutrients in India, Brazil, the United States, the United Kingdom, and internationally.

Adequate balance sheet average dividend payer.

Advertisement

Weekly Picks

JO
Jolt_Communications
MYSE logo
Jolt_Communications on Myseum ·

The Future of Social Sharing Is Private and People Are Ready

Fair Value:US$7.9577.4% undervalued
31 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TO
Tokyo
ASML logo
Tokyo on ASML Holding ·

EU#3 - From Philips Management Buyout to Europe’s Biggest Company

Fair Value:€1.31k6.4% undervalued
29 users have followed this narrative
4 users have commented on this narrative
11 users have liked this narrative
YI
BKNG logo
yiannisz on Booking Holdings ·

Booking Holdings: Why Ground-Level Travel Trends Still Favor the Platform Giants

Fair Value:US$5.47k6.3% undervalued
7 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
CO
composite32
SHEL logo
composite32 on Shell ·

A fully integrated LNG business seems to be ignored by the market.

Fair Value:UK£36.123.0% undervalued
38 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

TI
TibiT
OTB logo
TibiT on On the Beach Group ·

Sunny Returns with On the Beach

Fair Value:UK£3.0326.4% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
EM
PRESCO logo
emndy on Presco ·

High Quality Business and a true compounding machine

Fair Value:₦2.2k25.7% undervalued
12 users have followed this narrative
2 users have commented on this narrative
1 users have liked this narrative
CL
Clive_Thompson
ROG logo
Clive_Thompson on Roche Holding ·

Roche Holding AG To Benefit From Strong Drug Pipeline In 2027 And Beyond

Fair Value:CHF 430.0117.6% undervalued
10 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ·

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8236.2% undervalued
82 users have followed this narrative
6 users have commented on this narrative
35 users have liked this narrative
OO
NEO logo
OOO97 on Neo Performance Materials ·

Undervalued Key Player in Magnets/Rare Earth

Fair Value:CA$25.3324.6% undervalued
73 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0226.6% undervalued
1048 users have followed this narrative
6 users have commented on this narrative
31 users have liked this narrative
Advertisement